Logotype for Stratasys Ltd

Stratasys (SSYS) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Stratasys Ltd

Q3 2025 earnings summary

13 Nov, 2025

Executive summary

  • Delivered solid operating cash flow and positive adjusted EPS in Q3 2025, driven by disciplined cost management and operational excellence amid macro-driven caution in capital equipment sales.

  • Focused on high-value verticals such as aerospace, defense, automotive, dental, and medical, with strong customer engagement, infrastructure investments, and technology leadership to drive growth.

  • Strategic partnerships and wins in aerospace (Boeing, Embraer), defense (Honeywell, L3Harris), technology, and automotive (Andretti Global), with notable hardware sales growth year-over-year.

  • Expanded partnerships and new product launches in dental and automotive, including new leadership and innovative post-processing solutions.

  • Recurring revenue stability and expansion into key growth industries provide a foundation for future growth.

Financial highlights

  • Q3 2025 consolidated revenue was $137 million, down 2.1% year-over-year due to continued capital equipment spending constraints.

  • Product revenue was $94.1 million (flat year-over-year); service revenue was $42.9 million (down from $45.9 million).

  • GAAP gross margin was 41% (down from 44.8%); non-GAAP gross margin was 45.3% (down from 49.6%), mainly due to higher tariffs.

  • GAAP net loss was $55.6 million ($0.65/share), impacted by a $33.9 million non-cash impairment; non-GAAP net income was $1.5 million ($0.02/share).

  • Adjusted EBITDA was $5 million (vs. $5.1 million); operating cash flow was $6.9 million (vs. -$4.5 million); ended quarter with $255 million in cash and no debt.

Outlook and guidance

  • Reaffirmed full-year 2025 revenue guidance of $550–$560 million.

  • Non-GAAP gross margin expected at 46.7%–47%; non-GAAP operating margin at 1.5%–2%.

  • Adjusted EPS expected at $0.13–$0.16; adjusted EBITDA at $30–$32 million.

  • Non-GAAP operating expenses projected at $248M–$251M; capital expenditures expected at $20M–$25M.

  • Anticipates year-over-year growth in operating cash flow and gross margin improvement in Q4 2025 and into 2026, driven by price increases and cost actions.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more